Extra-fine Formoterol/Beclomethasone in the Treatment of Asthmatic Crisis

NCT02345993 Phase 4 UNKNOWN

The purpose of this study is to determine whether extra fine formoterol/beclomethasona are more effective in the treatment of asthmatic crisis when added to conventional treatment compared with conventional treatment alone.

Details

Lead sponsor	National Institute of Respiratory Diseases, Mexico
Phase	Phase 4
Status	UNKNOWN
Enrolment	120
Start date	2015-01
Completion	2015-08

Conditions

• Asthma
• Asthmatic Crisis

Interventions

• Extra fine Formoterol/Beclomethasone

Primary outcomes

• Pulmonary Function — 120 minutes
  change in Forced Expiratory Volume in 1 second (FEV1) with respect to basal

Countries

Mexico